2nd Annual Biomarkers & Precision Medicine USA Congress

With registration closing soon, and with only 10 passes left to attend the congress, do not miss your opportunity to sign up for the 2^nd Annual Biomarkers & Precision Medicine USA Congress, 9 – 11

 

Including over 40 presentations highlighting the latest trends and opportunities in biomarker discovery and clinical research strategies, this much-anticipated event is an unmissable opportunity to engage in scientific discussions on the future of the industry.

View the Agenda here: http://bit.ly/2feqU8H

 

Conference highlights & key presentations include:

 

• Biomarker Development in arthritis & Updates of FNIH: David Fox, University of Michigan & FNIH
• The Implications of the EU IVDR on CDx development: Colette Chevrier, EMD Serono
• Utility of prognostic and pharmacodynamic biomarkers in a phase 2 clinical trial in idiopathic pulmonary fibrosis: Brydon Bennett, Celgene
• Interactive program including Think Tank roundtable discussions & panel discussions

 

HOW TO REGISTER

For further information regarding the congress and possible discounted rates that can be applied to your company, please contact Angela Fernandez Saez  at a.fernandez@oxfordglobal.co.uk